Caspofungin in kidney transplant recipients with refractory invasive candidiasis.
Veroux
Massimiliano
M
Corona
Daniela
D
Macarone
Maurizio
M
Gagliano
Massimiliano
M
Giuffida
Giuseppe
G
Veroux
Pierfrancesco
P
D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy* / Q000209:etiology; D000077336:Caspofungin; D025141:Drug Resistance, Fungal; D054714:Echinocandins; D004947:Esophagus / Q000382:microbiology; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D055666:Lipopeptides; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D010456:Peptides, Cyclic / Q000009:adverse effects / Q000627:therapeutic use*; D014551:Urinary Tract / Q000382:microbiology
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D015725:Fluconazole; D000077336:Caspofungin